Symptom-based remote assessment in post treatment head and neck cancer surveillance: a prospective national study

ENT UK, BAHNO, INTEGRATE (The UK ENT Trainee Research Network)

Research output: Contribution to journalArticlepeer-review

37 Downloads (Pure)

Abstract

OBJECTIVES: To report the incidence of locoregional recurrence in head and neck cancer (HNC) patients under surveillance following treatment undergoing symptom-based remote assessment.

DESIGN: A 16-week multicentre prospective cohort study.

SETTING: UK ENT departments.

PARTICIPANTS: HNC patients under surveillance following treatment undergoing symptom-based telephone assessment.

MAIN OUTCOME MEASURES: Incidence of locoregional recurrent HNC after minimum 6-month follow-up.

RESULTS: Data for 1078 cases were submitted by 16 centres, with follow-up data completed in 98.9% (n = 1066). Following telephone consultation, 83.7% of referrals had their face-to-face appointments deferred (n = 897/1072). New symptoms were reported by 11.6% (n = 124/1072) at telephone assessment; 72.6% (n = 90/124) of this group were called for urgent assessments, of whom 48.9% (n = 44/90) came directly for imaging without preceding clinical review. The sensitivity and specificity for new symptoms as an indicator of cancer recurrence were 35.3% and 89.4%, respectively, with a negative predictive value of 99.7% (p = .002). Locoregional cancer identification rates after a minimum of 6 months of further monitoring, when correlated with time since treatment, were 6.0% (n = 14/233) <1 year; 2.1% (n = 16/747) between 1 and 5 years; and 4.3% (n = 4/92) for those >5 years since treatment.

CONCLUSIONS: Telephone assessment, using patient-reported symptoms, to identify recurrent locoregional HNC was widely adopted during the initial peak of the COVID-19 pandemic in the United Kingdom. The majority of patients had no face-to-face reviews or investigations. New symptoms were significantly associated with the identification of locoregional recurrent cancers with a high specificity, but a low sensitivity may limit symptom assessment being used as the sole surveillance method.

Original languageEnglish
Pages (from-to)561-567
JournalClinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
Volume47
Issue number5
Early online date30 May 2022
DOIs
Publication statusE-pub ahead of print - 30 May 2022

Bibliographical note

© 2022 John Wiley & Sons Ltd.

Keywords

  • multicentre
  • observational
  • outpatient
  • risk
  • triage

Fingerprint

Dive into the research topics of 'Symptom-based remote assessment in post treatment head and neck cancer surveillance: a prospective national study'. Together they form a unique fingerprint.

Cite this